Currently out of the existing stock ratings of Lauren Chung, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Lauren Chung

Work Performance Price Targets & Ratings Chart

Analyst Lauren Chung, carries an average stock price target met ratio of 33.33% that have a potential upside of 6.95% achieved within 61 days. Previously, Lauren Chung worked at JPMORGAN, WESTPARK, MAXIM GROUP.

Lauren Chung’s has documented 16 price targets and ratings displayed on 3 stocks. The coverage was on Healthcare, Technology sectors.

Most recent stock forecast was given on GRMN, Garmin Ltd at 02-Nov-2023.

Wall Street Analyst Lauren Chung

Analyst best performing recommendations are on GRMN (GARMIN LTD).
The best stock recommendation documented was for GRMN (GARMIN LTD) at 11/2/2023. The price target of $135 was fulfilled within 126 days with a profit of $26.26 (24.15%) receiving and performance score of 1.92.

Average potential price target upside

ZYNE Zynerba Pharmaceuticals GRMN Garmin Ltd BIOC Biocept

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Apr-2019

$1.11

$-0.19 (-14.62%)

3 years 1 months 14 days ago
(16-Aug-2023)

0/6 (0%)

$-0.18 (-13.95%)

Buy Since 07-Oct-2016

$23

3 years 1 months 15 days ago
(15-Aug-2023)

0/2 (0%)

$11.13 (93.77%)

Buy Since 14-Nov-2017

$8

5 years 1 months 28 days ago
(02-Aug-2021)

2/9 (22.22%)

$3.99 (99.50%)

113

Buy Since 31-Dec-2019

$7.25

$5.95 (457.69%)

$8.5

5 years 6 months 20 days ago
(10-Mar-2021)

1/4 (25%)

$2.91 (67.05%)

225

Buy Since 05-Jul-2018

$9

$7.7 (592.31%)

5 years 9 months 9 days ago
(21-Dec-2020)

0/4 (0%)

$5.56 (161.63%)

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?